Outcomes of passive-active immunoprophylaxis given to infants of mothers infected with hepatitis B virus in Babol, Iran.

[1]  Yukai Du,et al.  Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission , 2010, BMC infectious diseases.

[2]  S. Thompson.  Perinatal transmission of hepatitis B virus: an Australian experience , 2009, The Medical journal of Australia.

[3]  P. Ferrante,et al.  [Viral infections of the fetus and newborn infant]. , 2008, La Pediatria medica e chirurgica : Medical and surgical pediatrics.

[4]  Xiao-Min Xiao,et al.  Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy , 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  J. Brok,et al.  Hepatitis B immunisation for newborn infants of hepatitis B surface antigen‐positive mothers , 2006 .

[6]  J. Brok,et al.  Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis , 2006, BMJ : British Medical Journal.

[7]  M. Ramsay,et al.  Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation. , 2005, Vaccine.

[8]  Y. Pasha,et al.  Revaccination of non-responding infants delivered by HBsAg-positive mothers , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[9]  S. Ranger-Rogez,et al.  Hepatitis B mother-to-child transmission , 2004, Expert review of anti-infective therapy.

[10]  Man-Fung Yuen,et al.  Viral hepatitis B , 2003, The Lancet.

[11]  Hong Yang,et al.  Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies , 2003, Journal of medical virology.

[12]  H. Janssen,et al.  Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection , 2003, Journal of viral hepatitis.

[13]  Guangjun Yu,et al.  A randomized control trial on interruption of HBV transmission in uterus. , 2003, Chinese medical journal.

[14]  M. Rangel,et al.  Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women , 2003, The Pediatric infectious disease journal.

[15]  James B. Hill,et al.  Risk of Hepatitis B Transmission in Breast‐fed Infants of Chronic Hepatitis B Carriers , 2002, Obstetrics and gynecology.

[16]  H. Niesters,et al.  Letters to the Editor: Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients , 2000 .

[17]  J. Hadler,et al.  FOLLOW‐UP OF INFANTS OF HEPATITIS B‐INFECTED WOMEN AFTER HEPATITIS B VACCINATION, CONNECTICUT, 1994 TO 1997 , 2000, The Pediatric infectious disease journal.

[18]  K. K. Datta,et al.  Response to hepatitis B vaccination in high risk population. , 2000, The Journal of communicable diseases.

[19]  R. D. de Man,et al.  Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. , 2000, Journal of hepatology.

[20]  F. Mahoney,et al.  Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection , 1999, Clinical Microbiology Reviews.

[21]  A. Meheus,et al.  Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates , 1999, Journal of viral hepatitis.

[22]  C. Shapiro,et al.  Epidemiology of hepatitis B. , 1993, The Pediatric infectious disease journal.

[23]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[24]  W P Havens,et al.  Viral hepatitis. , 1970, The Medical clinics of North America.

[25]  Hal B. Jenson,et al.  Nelson Textbook of Pediatrics , 1965 .